Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02958592

Enrollment

121

Registered

2016-11-08

Start date

2015-06-30

Completion date

2016-10-31

Last updated

2016-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Fibrosis, Liver Tumor

Keywords

shear-wave elastography, hepatic fibrosis, liver tumor

Brief summary

To evaluate the diagnostic performance of two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection, using resected tissue pathology as a reference standard.

Interventions

OTHERtwo-dimensional shear-wave elastography (SWE)

performa two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* (i) patients with a solid focal liver lesion that was pathologically proven or diagnosed by imaging methods such as conventional US, CT or MR imaging; (ii) patients scheduled to undergo a hepatectomy; (iii) patients with a lesion ≥1.0 cm in diameter.

Exclusion criteria

* (i) patients with a history of chemotherapy; (ii) patients unable to properly hold their breath.

Design outcomes

Primary

Measure	Time frame	Description
Stage of hepatic fibrosis	within the first 7 days after surgery	compare the stage of hepatic fibrosis between SWE test with specimens after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026